COM:CARDIOLRX
Cardiol Therapeutics Inc.
- Stock
Last Close
2.22
22/11 21:00
Market Cap
189.75M
Beta: -
Volume Today
109.83K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 3.17M - | 3.73M 17.63% | 568.36K 84.77% | 8.98K 98.42% | ||||
average payables | 1.16M - | 1.07M 7.62% | 7.99M - | |||||
average receivables | 281.26K - | 694.32K 146.86% | 573.90K 17.34% | 313.52K 45.37% | 443.66K 41.51% | 380.03K 14.34% | ||
book value per share | 0.13 - | 1.45 1,052.99% | 0.57 60.78% | 0.44 21.78% | 1.76 296.85% | 0.84 52.65% | 0.44 47.53% | |
capex per share | -0.00 - | -0.00 30.16% | -0.02 1,731.70% | -0.00 91.72% | -0.00 78.03% | -0.00 299.98% | -0.00 16.53% | |
capex to depreciation | -0.55 - | -0.15 72.44% | -2.82 1,769.48% | -0.18 93.72% | -0.06 66.87% | -0.34 479.77% | -0.26 23.78% | |
capex to operating cash flow | 0.02 - | 0.00 94.39% | 0.04 2,845.27% | 0.00 88.14% | 0.00 87.59% | 0.00 400.45% | 0.00 6.94% | |
capex to revenue | -0.16 - | |||||||
cash per share | 0.10 - | 1.09 948.89% | 0.27 75.25% | 0.47 74.37% | 1.94 313.22% | 0.95 50.98% | 0.54 43.04% | |
days of inventory on hand | ||||||||
days payables outstanding | 11.21K - | |||||||
days sales outstanding | 1.89K - | |||||||
debt to assets | 0.06 - | 0.01 81.52% | 0.01 12.82% | 0.01 19.94% | 0.00 86.42% | 0.00 12.20% | 0.00 63.34% | |
debt to equity | 0.07 - | 0.01 81.85% | 0.01 7.57% | 0.01 9.25% | 0.00 86.93% | 0.00 9.49% | 0.00 59.91% | |
dividend yield | ||||||||
earnings yield | -0.02 - | -0.23 1,218.35% | -0.12 49.11% | -0.25 110.40% | -0.25 1.31% | -0.27 8.82% | -0.40 48.48% | |
enterprise value | 92.08M - | 51.95M 43.59% | 111.50M 114.64% | 69.13M 38.00% | 16.93M 75.51% | -16.27M 196.10% | 36.21M 322.61% | |
enterprise value over ebitda | -59.95 - | -7.12 88.13% | -8.30 16.62% | -3.39 59.13% | -0.37 88.97% | 0.32 186.77% | -1.23 477.73% | |
ev to operating cash flow | -71.26 - | -4.77 93.31% | -9.80 105.47% | -7.53 23.18% | -0.72 90.45% | 0.60 183.15% | -1.44 340.64% | |
ev to sales | 214.93 - | |||||||
free cash flow per share | -0.06 - | -0.71 1,119.50% | -0.46 35.57% | -0.31 32.40% | -0.55 76.43% | -0.44 19.90% | -0.39 10.32% | |
free cash flow yield | -0.01 - | -0.16 1,037.29% | -0.10 37.40% | -0.11 11.36% | -0.23 110.50% | -0.63 170.48% | -0.36 43.75% | |
graham net net | 0.09 - | 1.16 1,175.55% | 0.29 75.37% | 0.39 35.65% | 1.68 333.01% | 0.80 52.35% | 0.41 48.25% | |
graham number | 0.45 - | 5.81 1,176.69% | 2.63 54.68% | 2.63 0.05% | 4.76 81.17% | 1.86 60.94% | 2.07 11.44% | |
income quality | 0.78 - | 0.69 11.90% | 0.83 21.33% | 0.45 46.49% | 0.74 67.27% | 0.88 18.23% | 0.90 1.72% | |
intangibles to total assets | 0.22 - | 0.03 88.49% | 0.04 37.97% | 0.03 17.48% | 0.00 85.21% | 0.00 10.13% | 0 100% | |
interest coverage | -26.34 - | -11.30 57.12% | -21.87K 193,533.72% | 2.59 - | ||||
interest debt per share | 0.01 - | 0.06 449.75% | 0.01 87.78% | 0.01 29.24% | 0.00 48.12% | -0.31 11,471.49% | 0.00 100.08% | |
inventory turnover | ||||||||
invested capital | 0.07 - | 0.01 81.85% | 0.01 7.57% | 0.01 9.25% | 0.00 86.93% | 0.00 9.49% | 0.00 59.91% | |
market cap | 94.25M - | 68.41M 27.42% | 118.27M 72.88% | 83.00M 29.82% | 100.71M 21.33% | 43.13M 57.17% | 70.91M 64.41% | |
net current asset value | 2.12M - | 21.62M 920.54% | 13.54M 37.36% | 12.33M 8.96% | 75.50M 512.49% | 51.61M 31.64% | 27.70M 46.33% | |
net debt to ebitda | 1.41 - | 2.26 59.90% | 0.50 77.67% | 0.68 35.14% | 1.85 172.03% | 1.19 35.99% | 1.17 0.88% | |
net income per share | -0.07 - | -1.03 1,313.66% | -0.54 47.62% | -0.69 27.71% | -0.57 17.29% | -0.18 67.77% | -0.44 136.71% | |
operating cash flow per share | -0.06 - | -0.71 1,145.45% | -0.44 37.81% | -0.31 30.19% | -0.54 77.11% | -0.44 20.08% | -0.39 10.30% | |
payables turnover | 0.03 - | |||||||
receivables turnover | 0.19 - | |||||||
research and ddevelopement to revenue | 138.02 - | |||||||
return on tangible assets | -0.66 - | -0.66 0.39% | -0.94 41.50% | -1.34 43.12% | -0.28 78.88% | -0.19 33.95% | -0.77 310.64% | |
revenue per share | 0.00 - | |||||||
roe | -0.58 - | -0.71 22.61% | -0.95 33.57% | -1.56 63.26% | -0.32 79.16% | -0.22 31.94% | -1.00 351.15% | |
roic | -0.54 - | -0.17 68.59% | -0.92 440.49% | -1.52 64.58% | -0.46 69.38% | -0.36 22.91% | -1.05 192.56% | |
sales general and administrative to revenue | 353.90 - | |||||||
shareholders equity per share | 0.13 - | 1.45 1,052.99% | 0.57 60.78% | 0.44 21.78% | 1.76 296.85% | 0.84 52.65% | 0.44 47.53% | |
stock based compensation to revenue | 107.90 - | |||||||
tangible asset value | 2.14M - | 21.64M 912.75% | 14.12M 34.74% | 12.81M 9.33% | 75.86M 492.34% | 51.91M 31.57% | 28.25M 45.58% | |
tangible book value per share | 0.09 - | 1.41 1,396.14% | 0.55 61.15% | 0.43 21.58% | 1.76 309.17% | 0.83 52.68% | 0.44 47.23% | |
working capital | 2.31M - | 21.89M 848.18% | 13.68M 37.49% | 12.43M 9.13% | 75.58M 507.92% | 51.63M 31.68% | 27.86M 46.05% |
All numbers in CAD (except ratios and percentages)